Ruth Coleman

Picture of Ruth Coleman

Position:Senior Research Statistician

Telephone:01865 857253


Ruth is a Senior Research Statistician at the Diabetes Trials Unit.

Her ongoing projects include the expansion of the UKPDS Risk Engine to include estimates of both cardiovascular and microvascular disease risk, and modelling life expectancy in type 2 diabetes.

She is currently the statistical lead for the ACE study.

Latest publications

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial
Nantia Othonos et al.
Nat Commun. 2023

Joint longitudinal and time-to-event modeling compared with standard Cox modeling in patients with type 2 diabetes with and without established cardiovascular disease: an analysis of the EXSCEL trial
Abderrahim Oulhaj et al.
Diabetes Obes Metab. 2023

Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study
Shishi Xu et al.
Cardiovasc Diabetol. 2022;21:182

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials
David Preiss et al.
Diabetes Care 2022;45:e1-e2

Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
Marcus Lind et al.
Diabetes Care 2021;44:2231-2237

Predicting the Risk of Developing Type 2 diabetes in Chinese People who have Coronary Heart Disease and Impaired Glucose Tolerance
Shishi Xu et al.
Journal of Diabetes 2021;13:817-826